Introduction {#Sec1}
============

The burden of cognitive dysfunction is increasing due to population aging, and to a growing prevalence of predisposing conditions, such as obesity^[@CR1]^. Mental health disorders (either emotional, behavioural or other) have high lifetime prevalence, with first onset usually in childhood or adolescence^[@CR2]^. Brain and cognitive development prevail in early life, predicting later brain health^[@CR3]--[@CR5]^. Thus, it may be possible and important to recognize and alleviate early risk determinants. Early life phases are characterized by gut microbiota colonization^[@CR6],[@CR7]^. Gut bacteria regulate body metabolism, eating behaviour, adiposity and systemic inflammation^[@CR8],[@CR9]^, and have been recently associated with cognitive disorders in adult humans^[@CR10]^ and rodents^[@CR11],[@CR12]^. In an adult mouse model of cognitive pathology, we have identified specific microbiota signatures, and additive effects of high-fat feeding^[@CR13]^, correlating with cognitive dysfunction and brain glucose metabolism. We also observed that brain metabolic responses to acute intranasal insulin administration were compromised^[@CR14]^, in line with the involvement of cerebral insulin resistance in neurodegenerative conditions^[@CR15],[@CR16]^.

A growing number of pregnant women are overweight^[@CR17]^, and gestational overweight associates with lower cognitive abilities and behavioural disorders in the offspring, including anxiety, depressive-like behaviour, autism spectrum disorders, attention deficit hyperactivity disorders^[@CR18],[@CR19]^, from childhood^[@CR20]--[@CR24]^, but not yet at weaning^[@CR25],[@CR26]^. In rodents, maternal high-fat diet (HFD) results in systemic and hippocampal-hypothalamic inflammation^[@CR18]^ and damage^[@CR27]--[@CR29]^, with persistent changes in behaviour and learning^[@CR18]^, food intake and energy expenditure^[@CR30]^. Few studies have examined the effects of maternal obesity or HFD on the offspring's gut microbiota. Some show reductions in *Bacteroides*^[@CR31]^, Proteobacteria^[@CR32],[@CR33]^, and *Eubacterium* and *Blautia*^[@CR34]^, and increases in *Enterococcus*^[@CR31]^, *Bacteroides* and *Staphylococcus*^[@CR35]^, or *Oscillibacter*, *Parabacteroides* and unclassified Bacteroidales^[@CR34]^. Others report very limited and short-lasting effects^[@CR36]--[@CR38]^. In rodents and primates, the impact of maternal HFD on gut microbiota composition was not fully normalized by post-natal control diet^[@CR39],[@CR40]^.

In the current study, we hypothesized that brain function and gut microbiota are influenced by maternal gestational HFD, and that the gut microbiota might explain the dual dysregulation in eating behaviour and memory and exploratory behaviour in the offspring of HFD dams. We also considered that the bacterial taxa relating to brain function in early and later life might differ, and their distinct identification is important when considering microbiota-based preventive strategies along life-course phases. Our aim was to examine, in a murine model, the effects of maternal HFD on memory and exploratory behaviour, cerebral metabolism, gut microbiota, and their relationship at weaning and adult age, accounting for eating behaviour, body weight, and inflammatory profiles. Since the microbiota has different composition in the adult caecum and colon^[@CR13]^, we examined both intestinal tracts.

Results {#Sec2}
=======

General characterization {#Sec3}
------------------------

As expected, HFD mothers (HFDm) showed ∼28% heavier body weight (31.5 ± 3.9 vs 24.8 ± 0.5 g, p = 0.18) and ∼11% higher glycemia (8.3 ± 0.2 vs 7.5 ± 0.1 mmol/L, p = 0.004), consistent with greater energy intake from fat (956 ± 247 vs 103 ± 12 kcal, p = 0.012), compared to ND mothers (NDm). HFDm offspring were characterized by significantly higher random glycemia compared to controls (Fig. [1A](#Fig1){ref-type="fig"}). Daily food intake was significantly greater in mice born to HFD dams, starting 3 weeks post-weaning, and more markedly after 3 months of age (adulthood) (Fig. [1B](#Fig1){ref-type="fig"}). Consequently, overweight was progressive in this group, starting from 5 weeks post-weaning (Fig. [1C](#Fig1){ref-type="fig"}). At 6 months, HFDm offspring showed elevated leptin and resistin, and lower insulin and monocyte chemoattractant protein-1 (MCP-1) levels compared to age-matched controls (Fig. [1D,E](#Fig1){ref-type="fig"}).Figure 1Glycemia, food intake, body weight and circulating markers. Offspring of HFD mothers showed higher random glycemia (**A**) and daily food intake (**B**) at weaning and throughout growth compared to offspring of ND mothers, consistent with a greater body weight starting from 5 weeks of age (**C**). Circulating levels of insulin and cytokines were not different between groups at weaning (**D**); at 6 months of age the offspring of HFD mothers showed higher leptin and resistin, and lower insulin and MCP1 levels compared to age-matched controls (**E**). In line graphs, data are presented as mean ± SEM. In boxplots, black points represent outliers, i.e. cases with values between 1.5 and 3 times the interquartile (IQ) range. \*p \< 0.05.

Memory, exploratory behaviour and cerebral metabolism {#Sec4}
-----------------------------------------------------

At weaning, memory (alternation triplets) and locomotor (total arm entries and distance travelled) parameters were not reduced in HFDm than NDm offspring (Fig. [2A--C](#Fig2){ref-type="fig"}). Latency and resting time, travelled distance and speed were not different between groups. In adult HFDm offspring (Fig. [2E--G](#Fig2){ref-type="fig"}), all Y-maze parameters were impaired compared to controls. HFDm offspring showed significantly lower cerebral density compared to age-matched controls (Fig. [2D,H](#Fig2){ref-type="fig"}). Leptin was correlated inversely with memory (alternation triplets) and exploratory function (total arm entries and distance travelled) at one month (r = −0.51--075, p \< 0.05), and at 6 months (r = −0.49--0.61, p \< 0.05).Figure 2Cognitive function parameters, brain density at weaning (**A**--**D**) and 6 months (**E**--**H**). White bars (NDm), black bars (HFDm). Data are presented as mean ± SEM, \*\*p \< 0.01, \*p \< 0.05, ^\#^p ≤ 0.07.

Intranasal insulin (INI) administration reduced systemic glucose levels in adults (Fig. [3A,D](#Fig3){ref-type="fig"}). At baseline, brain glucose uptake (GU) was not different between groups (Fig. [3B,C,E,F](#Fig3){ref-type="fig"}). In NDm offspring, intranasal insulin delivery caused a 40--50% decrease from baseline in brain glucose uptake during adulthood (Fig. [3E](#Fig3){ref-type="fig"}). Instead, HFDm offspring were characterized by a significant response to insulin during infancy (Fig. [3C](#Fig3){ref-type="fig"}) and a blunted response during adulthood (Fig. [3F](#Fig3){ref-type="fig"}).Figure 3Systemic (**A**,**D**) and cerebral (**B**,**C**,**E**,**F**) effects of intranasal insulin administration. Circulating glucose levels and cerebral glucose uptake were measured in fasting conditions (−) and in response to acute intranasal insulin administration (+). Data are presented as mean ± SEM, \*\*p \< 0.01, \*p \< 0.05.

Microbiota composition in caecum and colon {#Sec5}
------------------------------------------

Based on canonical correspondence analysis (CCA) of microbiota composition (Table [S1](#MOESM1){ref-type="media"}, Fig. [4](#Fig4){ref-type="fig"}), group differences occurred earlier in the colon than in the caecum. Microbiota composition (e.g. operational taxonomic units, OTUs, Fig. [4](#Fig4){ref-type="fig"}) was clearly separated between NDm and HFDm offspring at both 1 and 6 months of age in the colon (Fig. [4B,D](#Fig4){ref-type="fig"}), and only at 6 months of age in the caecum (Fig. [4C](#Fig4){ref-type="fig"}). These findings were consistent across taxa levels (phylum, order, family, genus) (Table [S1](#MOESM1){ref-type="media"}). In 1 month old mice, no enrichment or depletion in the microbiota profile was observed at phylum, class and order level in the caecum (Fig. [5A](#Fig5){ref-type="fig"}) in HFDm compared to NDm; in the colon, the Tenericutes phylum, Mollicutes class, and RF39 order showed significant predominance in HFDm offspring (Fig. [5B](#Fig5){ref-type="fig"}). More group-specific microbiota hallmarks were observed at family, genus (Fig. [5B](#Fig5){ref-type="fig"}) and OTUs levels (Fig. [S1A,B](#MOESM1){ref-type="media"}). At 6 months, there were significant discriminant biomarkers at all taxa levels. Both in colon and caecum, Proteobacteria and Actinobacteria phyla prevailed in 6 months old HFDm offspring, whereas Firmicutes prevailed in 6 months old NDm offspring.Figure 4Multivariate canonical correspondence analysis (CCA) of gut microbiota. Association between maternal habitus (NDm vs HFDm) and microbiota composition (OTU level) at 1 month (**A**,**B**) and 6 months of age (**C**,**D**) in the caecum and colon. Microbiota composition was significantly separated between groups at both 1 and 6 months of age in the colon (**B**,**D**), and only at 6 months of age in the caecum (**C**).Figure 5Linear discriminanant analysis (LDA) effect size method (LEfSE) of gut microbiota. Bacteria taxa at phylum, class, order, family and genus levels (LDA score \>3) explaining the difference in microbiota composition in the caecum (**A**) and colon (**B**), between offspring of mothers fed normal diet (NDm) or high-fat diet (HFDm) at 1 and 6 months of age.

Associations between colon microbiota and memory and exploratory behaviour {#Sec6}
--------------------------------------------------------------------------

In one month old mice (Fig. [6A](#Fig6){ref-type="fig"}), a strong correlation was observed between the increase in Firmicutes phylum bacteria and the decline in alternation triplets (reflecting memory and cognitive function), remaining significant after controlling false discovery rate (FDR) by Benjamini-Hochberg procedure. Bacteria explaining this negative correlation belonged to Bacilli (Staphylococcaceae family, *Staphylococcus* genus), Clostridia (Christenellaceae and Clostridiaceae families), and Erysipelotrichia classes (Erysipelotrichaceae family). Positive correlations were observed between cognitive function and the *Dorea* genus (Firmicutes phylum), *Bifidobacterium* genus (Actinobacteria phylum), and unclassified Enterobacteriaceae genera (Proteobacteria phylum). The only genera that were associated with both maternal habitus and cognitive function were the *Aanerotruncus* and *Clostridium* genera (Clostridia class).Figure 6Correlation between maternal habitus, memory and behavioural parameters and colon microbiota. Heatmaps showing Spearman's correlation coefficients linking colon microbiota taxa and maternal obesity (ND vs HFD), memory and exploratory behaviour parameters at 1 month (**A**) and 6 months of age (**B**). Assigned phyum is indicated above bacterial names. \*p ≤ 0.05 in the univariate analysis, \*\*p ≤ 0.05 in the FDR-corrected analysis.

In 6 months old mice (Fig. [6B](#Fig6){ref-type="fig"}), a strong correlation was observed between the increase in Proteobacteria phylum bacteria and the decline in total arm entries, reflecting exploratory behaviour, remaining significant after FDR adjustment. Abundance in genera belonging to Proteobacteria phylum (unclassified *Moraxellaceae*, *Acinetobacter*), and Actinobacteria phylum (*Corynebacterium*) were predictive of lower cognition, whereas higher cognition was related with an increased abundance of *Anaerostipes* (Firmicutes phylum) and unclassified Enterobacteriaceae (Proteobacteria phylum). Exploratory behaviour was strongly associated (surviving FDR correction) with reduction in the abundance of Proteobacteria phylum (mainly in *Desulfovibrio spp*.), and Porphyromonadaceae, *Parabacteroides*, unclassified Rikenellaceae (Bacteroidetes phylum), while showing positive relationships with relative abundance of *Lactobacillus* (Firmicutes phylum). Notably, the panel showing strongest negative correlations with memory or exploratory behavior, i.e. surviving FDR adjustment (1 phylum: Proteobacteria, p = 0.049, 2 families: Rikenellaceae and Porphyromonadaceae, p = 0.001, and 2 genera: *Parabacteroides* and unclassified *Rikenellaceae*, p = 0.002, with *Desulfovibrio*, *p* = *0*.*056*), was also identified in LEfSe analysis in 6 months old HFDm offspring (Fig. [5B](#Fig5){ref-type="fig"}), and most of its components (Rikenellaceae and Porphyromonadaceae families, and unclassified Rikenellaceae and Parabacteroides genera) were already increased in HFDm offspring at the age of 1 month (Fig. [5A](#Fig5){ref-type="fig"}). In addition, among these genera, *Desulfovibrio*, *Parabacteroides* and unclassified Rikenellaceae were also positively correlated with food intake or body weight in adults, though only in univariate analysis (Table [S2](#MOESM1){ref-type="media"}).

Microbiota metabolic pathways (KEGG) in colon {#Sec7}
---------------------------------------------

In global multivariate analyses of KEGG derived metabolic pathways, a significant difference was found in the colon (p = 0.05 by CCA) in 6 months old NDm and HFDm offspring (Table [S3](#MOESM1){ref-type="media"}). No global difference was observed in the caecum or in 1 month old animals. At the level of specific KEGG derived pathways, fold-change and LEfSe analyses (Figs [7A,B](#Fig7){ref-type="fig"}, [S2](#MOESM1){ref-type="media"}) revealed significant group differences at both ages, with HFDm offspring showing upregulation of pathways involved in energy metabolism, (mostly essential) aminoacids (phenylalanine at 1 and 6 months, lysine and tryptophan at 1 month, cianoaminocid at 6 months), glucose and lipid metabolism, secondary metabolites, and endocrine system. At 6 months, there was also overexpression of pathways involved in sulfur metabolism and nervous system, i.e. glutamatergic synapse, protein folding, phosphatydilinositol signaling, arachidonic acid, ion channels and Alzheimer's disease.Figure 7Colon microbiota functional analysis. Predictive functional analysis using PICRUSt with Kyoto Encyclopaedia of Genes and Genomes (KEGG) revealed colon microbiota-derived pathways that were differently regulated in the offspring born to mothers fed high-fat versus normal diet, both at 1 (**A**) and 6 months of age (**B**). The identified pathways are implicated in metabolism, genetic information processing, environmental information processing, cell motility, endocrine and nervous system and human diseases, and drug development. Pathways with a relative fold-change \>10% and a significant difference (p \< 0.05) between NDm and HFDm offspring in the Wilcoxon-rank test are shown.

Discussion {#Sec8}
==========

The main novelties of this study consist in the identification of early gut signatures that persist through adulthood, which depend on maternal diet and strongly predict adulthood cognitive and exploratory behaviour, and in the quantification of brain responses to intranasal insulin stimulation *in vivo*, implicating cerebral insulin resistance in the cognitive deficit induced by maternal HFD.

Cognitive diseases are increasing in prevalence worldwide. Prenatal and early postnatal experiences are fundamental in brain development, and determine cognitive risk in adulthood^[@CR3]--[@CR5]^. Maternal pregravid body mass index (BMI) negatively predicts preschool and school children cognition^[@CR21],[@CR22],[@CR24]^ and development of other neuropsychiatric disorders such as anxiety, depressive-like behaviour, autism spectrum disorders, attention deficit hyperactivity disorders^[@CR19]^, but there seems to be a time-window, from birth to weaning^[@CR23],[@CR25],[@CR26]^, in which the negative effect of maternal obesity is not yet clinically detectable. In keeping with human data, we observed that memory and locomotor parameters were normal in HFDm offspring at end-lactation compared to age-matched controls. Conversely, a marked impairment in both functions was seen in adults, consistent with previous reports^[@CR18],[@CR28]^. The earliest brain abnormality was a reduction in cerebral density, which is coherent with the impairment in neurogenesis^[@CR18],[@CR27],[@CR41]^ seen in other offspring studies, and with cerebral density losses typically seen in patients with cognitive dysfunction and Alzheimer's disease^[@CR42]--[@CR44]^. Our HFDm pups had normal weight and fasting glucose levels, consistent with previous evidence in mice^[@CR39]^, though random glucose assessments were suggestive of post-prandial hyperglycemia, likely due to fat consumption in breast milk. HFDm offspring became hyperphagic after 3 weeks post-weaning, consistent with the early programming of circuitries involved in appetite control^[@CR45]--[@CR47]^. They progressively showed overweight, hyperglycemia, -leptinemia, -resistinemia and low insulin and MCP-1 levels compared to NDm offspring. Impaired beta cell insulin secretion in adult offspring of obese mothers has been previously reported^[@CR48],[@CR49]^, although the mechanism needs to be better explored. MCP-1 expression is insulin-responsive^[@CR50]^, thus the decreased insulin secretion found in adult offspring of HFD mother in our model might be responsible for lower MCP-1. Overall, these hormonal changes support the link of memory impairment, peripheral dysmetabolism and central insulin resistance^[@CR51]^.

Cerebral insulin resistance has been implicated in the pathogenesis of Alzheimer's disease^[@CR15],[@CR16]^, and our findings extend this association to the offspring of HFD mothers. In the present study, we examined brain GU before and after a direct administration of insulin in the brain, without manipulating peripheral glycemia. Intranasal insulin administration resulted in a lowering of glycemia, reducing brain GU in adult controls, which is coherent with previous studies showing that cerebral insulin delivery stimulates hepatic glucose uptake and conversion into glycogen^[@CR52]--[@CR54]^, and reduced endogenous glucose production (i.e. liver glucose production)^[@CR55],[@CR56]^. In our model, brain response to INI in the offspring of HFDm was significantly greater at weaning and blunted (statistical significance reached only in 4 brain regions out of 11 examined) in adult age compared to controls. This is consistent with our previously published data showing that during peripheral insulin infusion in a hyperinsulinaemic-isoglycaemic clamp, brain glucose uptake in minipigs of HFD mothers was elevated in early life, and defective during young adulthood, being paralleled by cortical and hypothalamic expression of insulin receptors and insulin-sensitive glucose transporters^[@CR57]^. The study suggested that the brain of animals born to obese sows was initially hypersensitive to insulin, and then became insulin resistant^[@CR57]^. However, we could not measure cognitive function in pigs, and insulin was not selectively administered into the brain. In the present study, we demonstrate that brain insulin sensitivity was present together with normal memory and explorative performance in early HFDm offspring, whereas cerebral insulin resistance occurred together with impairment in memory and explorative behaviour in adults born to HFD mothers. These timelines might suggest that maternal obesity associates with early brain maturation followed by early deterioration in the offspring, and that there might be a time-window for effective prevention.

In recent years, intensive research efforts have been devoted to the identification of microbiota-based targets for early risk detection and prevention of chronic diseases, and strong support of a causal link between microbiota composition and neurodegeneration has been provided^[@CR58]^. Therefore, we focused on the identification of bacterial candidates that may be linked to cognitive or behavioural disorders and its impairment in the offspring of HFD dams. Our results confirm the excess observed in Firmicutes in early life in offspring of HFD dams^[@CR39]^, but the most relevant finding was that 1 and 6 months old HFDm offspring showed the same dominance of Parabacteriodes (Porphyromonadaceae) and unclassified Rikenellaceae (Bacteroidetes phylum) observed in strong, i.e. FDR adjusted correlation with impaired exploratory behviour in adults. *Desulfovibrio* genus was also inversely associated with exploratory behviour in adult mice, falling short of significance in FDR adjustment (p = 0.056). Interestingly, an increase in *Parabacteroidetes* has been described also in children born to obese mothers, conferring translational potential to our results^[@CR34]^. The identified taxa are coherent with observations in cognitively impaired SAMP8 mice, showing greater abundance of Proteobacteria-Desulfovibrionaceae and Rikenellaceae, and low abundance of *Ruminococcus* and *Anaerotruncus* in coherent association with cognitive abilities^[@CR59]^. Notably, these predictors of impairment in memory or exploratory function were not independently associated with food intake and/or overweight, after FDR correction. In synthesis, the above findings suggest that adverse microbiota changes induced by maternal HFD and associating with impairment in memory and exploratory function are seeded before weaning, and manifest their unfavourable cerebral action between weaning and adulthood.

We found also bacterial taxa that correlated with brain functional features, but were not dependent on maternal diet. The ones correlating with low cognition mostly belonged to the Firmicutes phylum in early life, and to Corynebacteriaceae (*Corynebacterium*) and Moraxellaceae (*Acinetobacter*) families in adults, whereas Enterobacteriaceae (Proteobacteria phylum) and Bifidobacteriaceae families (*Bifidobacterium* genus, Actinobacteria phylum) in early life, and *Lactobacillus*, *Anaerostipes* and Unclassified Enterobacteriaceae genera in adults were related to better memory and greater exploratory activity, and may be protective. Though most of these correlations lost full significance after FDR adjustment, they are in line with our reported dominance (Firmicutes phylum, Christenellaceae family, *Staphylococcus* genus) or depletion of specific bacteria taxa (Bifidobacteriaceae family, *Bifidobacterium* genus) in adult mice with genetically induced Alzheimer's type pathology^[@CR13]^, and with the evidence that *Lactobacillus*- and *Bifidobacterium*-based probiotics ameliorate minimental state examination score (+27%) and insulin sensitivity (+28%) in patients with Alzheimer's disease in 12 weeks^[@CR60]^.

Different mechanisms have been proposed to explain the cross-talk between gut bacteria and the central nervous system of mammals, including direct diffusion of microbiota metabolites across the gut wall, or the transport of microbiota-derived neurotransmitters via afferent neural circuits^[@CR61]^. We used KEGG pathway analysis to translate our microbiota composition data into biologically meaningful pathways, and most of the emerging pathways are recognized regulators of neurological function and appetite control. We found that lysine, phenylalanine, tryptophan pathways were overexpressed in HFDm offspring. Though essential aminoacids are required for health, their excess impairs neurological development^[@CR62]^. Lysine is involved in epigenetic regulation^[@CR63]^, and this pathway was affected in early life, when epigenetic modifications are prominent; moreover, the consensual change in fatty acid metabolic, TCA cycle, cell motility and secretion pathways at this age was in line with the known involvement of this aminoacid in regulating calcium intestinal absorption^[@CR64]^, and fatty acid mitochondria transport and oxidation^[@CR65]^. Among appetite regulators, tryptophan at 1 month and arachidonic acid at 6 months, were identified. The former is precursor of serotonin, and mostly produced by the gut to act on the brain and regulate appetite^[@CR66]^. Arachidonic acid was elevated by 2 folds in HFDm compared to NDm offspring, representing the highest group difference among all pathways. Arachidonic acid is precursor of the orexogenic endocannabinoids anandamide^[@CR67]^, and the most abundant fatty acid in the brain, with a fundamental role in early neurological development and neurodegenerative disease^[@CR68]^. Other disturbances in pathways related to neurodevelopment and neurodegeneration in our HFDm offspring were the overexpression of the phenylanine (precursor of tyrosine and L-DOPA^[@CR69]^) pathway, underexpression of the cyano-aminoacid (precursor of asparagine, essential for glutamate formation) pathway, and upregulation of the glutamatergic-synapse and ion channels pathways (favoring the dominance of excitatory versus inhibitory functions), as typically observed in neurodegenerative disorders^[@CR70]^. Several gut bacteria are able to produce glutamate or GABA^[@CR71]^, and it is of note that *Corynebacterium*, which is the main gut producer of glutamine, was a negative predictor, whereas *Lactobacillus* and *Bifidobacterium*, known to metabolize glutamate and produce GABA^[@CR71]^, were positive predictors of cognitive function. The upregulation of the sulfur metabolic pathway is also coherent with the excess in aminoacids (source of sulfur) and the high abundance of *Desulfovibrio* observed in HFDm offspring. One important observation was that, 6 months old HFD offspring displayed a significant upregulation of the Alzheimer's disease pathway, covering a large series of strictly pathogenetic genetic changes. Overall, remodeling of microbiota composition resulted in a metabolic configuration that could explain overeating behavior and impairment in memory and exploratory behavior in the offspring of HFD mothers.

Our study conveys novelty, but has limitations. To our knowledge, our results are the first to show the relationship linking brain dysfunction and dysbiosis, as a result of short- and long-term effects of maternal HFD, and to extend the evidence of cerebral insulin resistance to HFDm offspring, by using *in vivo* imaging approaches. However, our correlative analyses are not sufficient to dissect the causal role of maternal obesity versus microbiota changes (induced by maternal obesity) on the phenotype observed in the offspring. We also recognize that additional cognitive and behavioural tests or microbiota transplantation experiments, and molecular measurements may have added further support and insight (in)to our findings. A technical limitation in cerebral ^18^F-2-fluoro-2-deoxyglucose-positron emission tomography (FDG-PET) studies is that anaesthesia may lead to systematic underestimation in brain metabolism, though its influence on group comparisons was minimized by strictly reproducing the same protocol in all studies.

Conclusions {#Sec9}
===========

In conclusion, our animal model demonstrates that overeating, memory decline, exploratory abnormalities and cerebral insulin resistance are delayed phenomena in the offspring of HFD dams, which leaves a useful time-window open to prevention maneuvers. We identified a well-defined panel of bacteria taxa that are dependent on maternal status and strongly related with behavioural dysfunction in adult mice, and we documented that these same bacteria are overrepresented since early life in the offspring of HFD dams. These findings open the possibility of microbiota-targeted strategies to contrast cognitive and behavioural deviations.

Methods {#Sec10}
=======

Study design {#Sec11}
------------

B6129SF2/J (stock no: 101045, The Jackson Laboratory, Bar Harbor, Maine) female mice were randomly divided in: 1) normal diet-fed mothers (NDm, 11% kcals from fat, Mucedola, Italy, n = 5), and 2) high-fat diet-fed mothers (HFDm, 58% kcals from fat, Mucedola, n = 4). Following 3 months of diet, females were mated (B6129SF2/J males), and allowed to deliver spontaneously. Maternal diets were maintained through gestation and lactation. After weaning, offspring (total n = 45, NDm = 27 and HFDm = 18) were fed with standard diet. Animals were housed under standard conditions (22 °C, 12-hour light/dark cycles), with *ad libitum* access to food and water. From weaning, offspring's food intake and body weight were monitored weekly and glycemia every ∼7 weeks. At 1 (weaning, NDm/HFDm = 27/18 cognition and NDm/HFDm = 11/8 cerebral glucose metabolism) and 6 months of age (adulthood, NDm/HFDm = 11/10 cognition and NDm/HFDm = 10/8 cerebral glucose metabolism), cognitive function and cerebral glucose metabolism (at baseline and after intranasal insulin administration) were assessed. Then, animals were euthanized by anaesthetic overdose, and blood and brains collected. The experimental protocol was conducted in accordance with the D.L.116/92 implementation of EEC directive 609/86 regarding the protection of animals used for experimental and other scientific purposes. Veterinary and animal care staff was responsible for animal welfare and supervision.

Y-maze test {#Sec12}
-----------

Each animal was allowed to move freely through a standard 3-arm Y-maze (Panlab, Harvard Apparatus, Spain) for 8 minutes, under visual automatic tracking of latency time (until first arm choice), spontaneous alternation triplets (number of 3 consecutive entries in different arms), percentage of alternation triplets (against the maximum possible number), zone transition number, total arm entries, resting time, travelled distance and speed.

Brain glucose metabolism {#Sec13}
------------------------

Imaging of ^18^F-2-fluoro-2-deoxyglucose by positron emission, computed tomography (\[^18^F\]FDG PET-CT, IRIS, Inviscan SAS, France) was performed under fasting and insulin-stimulated conditions. Anaesthesia was induced and maintained in overnight-fasted mice by ∼3% and ∼2% (v/v) isofluorane inhalation (IsoFlo®, Abbott Laboratories, IL, USA). Breath frequency and temperature were monitored during the study and a heated pad was used to prevent hypothermia. An intraperitoneal catheter was placed for tracer administration. A 60-minute whole-body dynamic PET scan was acquired in fasting conditions after \[^18^F\]FDG injection. Then, intranasal insulin was administered (0.29/0.87 UI in 8/24 μl, 1/6 months, Sigma-Aldrich, MO, USA), as described^[@CR20]^. Thirty minutes later, \[^18^F\]FDG injection and PET scanning were repeated. Every 10 minutes, glycemia was measured in tail blood by glucometer (OneTouch, Johnson&Johnson Medical SpA, Italy). PET data were corrected for dead time and radioactive decay, reconstructed by three-dimensional iterative ordered-subset expectation-maximization (3D-OSEM) algorithm, and co-registered to CT images by AMIDE Medical Image Data Examiner 1.0.5. Regions of interest were manually drawn on PET images in correspondence of thalamus, hypothalamus, hippocampus, amygdala, globus pallidus, striatum, frontal, medial, sensory and temporal cortex, and cerebellum. Activity levels in the brain regions were divided by the injected dose per gram of body weight (%ID/g), representing regional glucose fractional extraction, and multiplied by glycaemia, to reflect regional glucose uptake rates^[@CR57]^.

At the end of *in vivo* procedures, brains were collected and weighted in a subset of mice to determine their mass. Cerebral volumes were measured on computed tomography (CT) images by a semi-automatic segmentation procedure using the Seg3D software (v2.2.1). Cerebral density was computed as ratio of whole brain mass-to-volume.

Biochemical analyses {#Sec14}
--------------------

Blood samples were collected at the end of imaging procedures. Interleukin-6 (IL-6), Tumor Necrosis Factor-α (TNF-α), resistin, Plasminogen Activator Inhibitor-1 (PAI-1), Monocyte Chemoattractant Protein-1 (MCP-1), leptin, and insulin were assessed in plasma by Luminex® xMAP® technology (Mouse Adipokine Magnetic Bead Panel, Merck-Millipore Corp., MO, USA), according to manufacturer's instructions.

Gut bacteria 16S rDNA gene sequencing {#Sec15}
-------------------------------------

Total DNA was isolated from caecum and colon content pellets by MasterPure Complete DNA&RNA Purification Kit (Epicentre, Illumina, WI, USA), as previously described^[@CR72]^. DNA was measured using a Qubit® 2.0 Fluorometer (Life Technology, CA, USA) and normalized to 10 ng/μL. The V3-V4 region of 16S rDNA gene was amplified by PCR using Illumina adapter overhang nucleotide sequences according to Illumina protocols. The multiplexing step was performed using Nextera XT Index Kit (Illumina, CA, USA). A Bioanalyzer DNA 1000 chip (Agilent Technologies, CA, USA) was used to check the PCR product, and libraries were sequenced using a 2 × 300 pb paired-end run (MiSeq Reagent kit v3) on a MiSeq-Illumina platform (FISABIO sequencing service, Valencia, Spain) according to manufacturer's instructions (Illumina). For quality control, reagents employed for DNA extraction and PCR amplification were also sequenced.Quality assessment was performed by prinseq-lite program (min_length:50; trim_qual_right:20; trim_qual_type:mean; trim_qual_window:20^[@CR73]^). R1 and R2 from sequencing where joined using fastq-join from ea-tools suite. Data were obtained using an ad-hoc pipeline written in R Statistics environment and data processing was performed by QIIME pipeline (version 1.9.0)^[@CR74]^, as previously described^[@CR13]^. Chimeric sequences and sequences that could not be aligned were removed. The clustered sequences were utilized to construct OTUs tables (97% identity), then classified into phylum, family, genus taxonomic levels based on the Greengenes database. Sequences not taxonomically classified, or belonging to Cyanobacteria and Chloroplasts (representing ingested plant material), were removed.

Statistical analysis {#Sec16}
--------------------

Calypso software version 8.84 was used with total sum normalization for the statistical analysis of microbiota data. Multivariate test canonical correspondence analysis (CCA) was used to assess complex association between gut bacteria community composition in the offspring and maternal diet. Linear discriminant analysis (LDA) effect size (LEfSe), were used to identify unique biomarkers (LDA score \>3.0) in relative abundance of bacterial taxonomy^[@CR75]^. Spearman's correlation analysis was used to explore univariate associations between bacteria taxa relative abundances and cognitive or anthropometric parameters. Predictive inferred functional analysis was performed using PICRUSt with Kyoto Encyclopedia of Genes and Genomes (KEGG)^[@CR76]^. Then, CCA, LEfSe analysis and Wilcoxon-rank test were used to explore associations between KEGG pathways and maternal groups. FDR-correction was applied in multiple comparisons analyses.

SPSS for MAC (version 22, Chicago, IL, USA) was used for the statistical analysis of other data. Variables distribution was tested by Shapiro-Wilk test. For normally distributed variables (e.g. glycemia, anthropometric and cognitive parameters) and variables normalized by logarithmic transformation (i.e. PET data), comparisons between groups were performed by two-tailed T-test for independent and paired samples. Mann-Whitney U test was used when normal distribution was not achieved (i.e. food intake and circulating biochemical markers). In group comparisons, values \>3 times the IQ range were excluded: 1 value for circulating leptin, PAI-1, resistin and TNF-alpha at weaning, 2 values for leptin and MCP-1 and 1 value for resistin and TNF-alpha at 6 months Results were presented as mean ± sem or median and interquartile range (circulating markers), P-values ≤ 0.05 were regarded as statistically significant.

Ethics approval {#Sec18}
---------------

The experimental protocol was conducted in accordance with the D.L.116/92 implementation of EEC directive 609/86 regarding the protection of animals used for experimental and other scientific purposes. Veterinary and animal care staff was responsible for animal welfare and supervision.
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